TrialJCO precision oncology2021

Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells.

Heather A Parsons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.